Nonsteroidal anti-inflammatory drugs in perisurgical pain management. Mechanisms of action and rationale for optimum use
- PMID: 7705216
- DOI: 10.2165/00003495-199549010-00005
Nonsteroidal anti-inflammatory drugs in perisurgical pain management. Mechanisms of action and rationale for optimum use
Abstract
Nonsteroidal anti-inflammatory drugs (NSAIDs) are a group of agents with similar actions but diverse chemical structures. Aspirin (acetylsalicylic acid) and sodium salicylate were the first drugs of this type to be used clinically. However, over the past 3 decades there has been a dramatic increase in the number of NSAIDs available for the treatment of postoperative pain. Tissue injury, such as occurs with surgical intervention, is associated with the release of numerous inflammatory mediators including prostaglandins. Prostaglandins derived from the arachidonic acid cascade are implicated in the production of inflammatory pain, and in sensitising nociceptors to the actions of other mediators. They are synthesised from arachidonic acid via the endoperoxide biosynthesis pathway, the initial step of which is catalysed by the enzyme cyclo-oxygenase. Two forms of the cyclo-oxygenase enzyme (COX-1 and COX-2) have been characterised. COX-1 is important in circumstances where prostaglandins have a protective effect such as gastric mucus production and renal blood flow maintenance. NSAIDs inhibit the synthesis of prostaglandins at 1 or more points in the endoperoxide pathway. Three mechanisms of inhibition of the biosynthetic enzymes have been proposed: (i) rapid, reversible competitive inhibition; (ii) irreversible, time-dependent inhibition; and (iii) rapid, reversible noncompetitive (free radical trapping) inhibition. In addition, there is evidence that NSAIDs have a central antinociceptive mechanism of action that augments the peripheral effect. This may involve inhibition of central nervous system prostaglandins or inhibition of excitatory amino acids or bradykinins. There is considerable variability in the pain relief obtained from NSAIDs. Such variability in drug response may be explained in terms of differences between agents with respect to either pharmacodynamic actions or pharmacokinetic parameters or a combination of both. Stereoisomerism, where preparations exist as racemic mixtures and where only 1 enantiomer is active, may also be important. However, chiral inversion from inactive to active enantiomer may occur and may be rapid or slow. NSAIDs have numerous adverse effects. Gastrointestinal disturbances including ulceration are the commonest adverse responses to NSAIDs and carry the greatest risk of death. Also significant are renal impairment and an increased risk of postoperative haemorrhage. Asthma and allergic reactions are uncommon.(ABSTRACT TRUNCATED AT 400 WORDS)
Similar articles
-
Dual acting anti-inflammatory drugs: a reappraisal.Pharmacol Res. 2001 Dec;44(6):437-50. doi: 10.1006/phrs.2001.0872. Pharmacol Res. 2001. PMID: 11735348 Review.
-
The mechanisms of action of NSAIDs in analgesia.Drugs. 1996;52 Suppl 5:13-23. doi: 10.2165/00003495-199600525-00004. Drugs. 1996. PMID: 8922554 Review.
-
The spinal actions of nonsteroidal anti-inflammatory drugs and the dissociation between their anti-inflammatory and analgesic effects.Drugs. 1994;47 Suppl 5:28-45; discussion 46-7. doi: 10.2165/00003495-199400475-00006. Drugs. 1994. PMID: 7525183 Review.
-
Nonsteroidal anti-inflammatory drugs in the management of pain and inflammation: a basis for drug selection.Am J Ther. 1999 Jan;6(1):3-11. doi: 10.1097/00045391-199901000-00002. Am J Ther. 1999. PMID: 10423641 Review.
-
COX-dependent mechanisms involved in the antinociceptive action of NSAIDs at central and peripheral sites.Pharmacol Ther. 2005 Aug;107(2):139-54. doi: 10.1016/j.pharmthera.2005.02.004. Epub 2005 Apr 19. Pharmacol Ther. 2005. PMID: 15993252 Review.
Cited by
-
Ibuprofen as a pre-emptive analgesic is as effective as rofecoxib for mandibular third molar surgery.Odontology. 2006 Sep;94(1):59-63. doi: 10.1007/s10266-006-0062-4. Odontology. 2006. PMID: 16998619 Clinical Trial.
-
Pharmacological targeting of bone marrow mesenchymal stromal/stem cells for the treatment of hematological disorders.Inflamm Regen. 2017 Apr 3;37:7. doi: 10.1186/s41232-017-0038-5. eCollection 2017. Inflamm Regen. 2017. PMID: 29259706 Free PMC article. Review.
-
Intravenous paracetamol reduces postoperative opioid consumption after orthopedic surgery: a systematic review of clinical trials.Pain Res Treat. 2013;2013:402510. doi: 10.1155/2013/402510. Epub 2013 Nov 6. Pain Res Treat. 2013. PMID: 24307945 Free PMC article. Review.
-
Ketorolac. A reappraisal of its pharmacodynamic and pharmacokinetic properties and therapeutic use in pain management.Drugs. 1997 Jan;53(1):139-88. doi: 10.2165/00003495-199753010-00012. Drugs. 1997. PMID: 9010653 Review.
-
The effects of paracetamol, ketorolac, and paracetamol plus morphine on pain control after thyroidectomy.Korean J Pain. 2010 Jun;23(2):124-30. doi: 10.3344/kjp.2010.23.2.124. Epub 2010 May 31. Korean J Pain. 2010. PMID: 20556214 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous